Human Von Willebrand Factor (VWF) Deficient Serum

<strong>Human Von Willebrand Factor (VWF) Deficient Serum</strong>_x000D_ <strong>Catalog number:</strong> B2015643_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mL_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Serun_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> Von Willebrand Factor, VWF, Von Willebrand Antigen II_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Bali DS, El-Gharbawy A, Austin S, Pendyal S, Kishnani PS. Glycogen Storage Disease Type I 2006 Apr 19 [updated 2021 Oct 14]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024._x000D_ 2: Cohen CT, Zobeck M, Powers JM. Initial von Willebrand factor antigen values in adolescent females predict future values Haemophilia. 2023 Nov;29(6):1547-1555._x000D_ 3: Bettoni S, Galbusera M, Gastoldi S, Donadelli R, Tentori C, Spartà G, Bresin E, Mele C, Alberti M, Tortajada A, Yebenes H, Remuzzi G, Noris M. Interaction between Multimeric von Willebrand Factor and Complement: A Fresh Look to the Pathophysiology of Microvascular Thrombosis J Immunol. 2017 Aug 1;199(3):1021-1040._x000D_ 4: Wang Q, Shorten D, Xu X, Shaw GD, Schaub RG, Shea C, Brooks J, Sako D, Wiswall E, Xu J, Szklut P, Patel VS. Effect of von Willebrand factor on the pharmacokinetics of recombinant human platelet glycoprotein Ibalpha-immunoglobulin G1 chimeric proteins Pharm Res. 2006 Aug;23(8):1743-9._x000D_ 5: Stoll G, Kleinschnitz C, Nieswandt B. The role of glycoprotein Ibalpha and von Willebrand factor interaction in stroke development Hamostaseologie. 2010 Aug;30(3):136-8._x000D_ 6: Saha M, McDaniel JK, Zheng XL. Thrombotic thrombocytopenic purpura: pathogenesis, diagnosis and potential novel therapeutics J Thromb Haemost. 2017 Oct;15(10):1889-1900._x000D_ 7: Mancuso ME, Mahlangu JN, Pipe SW. The changing treatment landscape in haemophilia: from standard half-life clotting factor concentrates to gene editing Lancet. 2021 Feb 13;397(10274):630-640._x000D_ 8: Goltz D, Hittetiya K, Yadegari H, Driesen J, Kirfel J, Neuhaus T, Steiner S, Esch C, Bedorf J, Hertfelder HJ, Fischer HP. ATZ11 recognizes not only Z-α1-antitrypsin-polymers and complexed forms of non-Z-α1-antitrypsin but also the von Willebrand factor PLoS One. 2014 Mar 19;9(3):e91538._x000D_ 9: Gerritsen HE, Robles R, Lämmle B, Furlan M. Partial amino acid sequence of purified von Willebrand factor-cleaving protease Blood. 2001 Sep 15;98(6):1654-61._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/37128920">10: Xu S, Piao L, Wan Y, Huang Z, Meng X, Inoue A, Wang H, Yue X, Jin X, Shi GP, Kuzuya M, Cheng XW. CTSS Modulates Stress-Related Carotid Artery Thrombosis in a Mouse FeCl(3) Model Arterioscler Thromb Vasc Biol. 2023 Jul;43(7):e238-e253. </a>_x000D_ _x000D_ <strong>Products Related to Human Von Willebrand Factor (VWF) Deficient Serum can be found at</strong> <a href="https://moleculardepot.com/product-category/Biofluids/"> Biofluids</a>